FDA is issuing more postmarketing requirements, but challenges with oversight persist

• Pubblicazione: [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2016
• Descrizione fisica: 1 online resource (26 pages) : illustrations
• Soggetto topico: Drugs - United States - Testing - Management; Clinical trials - Government policy - United States
• Note generali: Title from title screen (viewed Aug 9, 2016).; "July 2016."; "OEI-01-14-00390."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Food and Drug Administration is issuing more postmarketing requirements, but challenges with oversight persist; FDA is issuing more postmarketing requirements, but challenges with oversight persist
• Titolo autorizzato: FDA is issuing more postmarketing requirements, but challenges with oversight persist
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910707486803321
• Lo trovi qui: Univ. Federico II